Proof shows that individuals that do not obtain adequate omega-3s have a higher threat of eye diseases, with the exemption of completely dry eye disease.
Epanova (omega-3 carboxylic acids) was authorized on 23 April 2014. 2 newsletters, both quarterly, evaluating recent publications in vital fatty acids.